Search research articles
Contact Us
Filters
Showing results (21-30 of 106) with videos related to
Page
of 11
Sort By:
Pharmacoeconomics
|
July 28, 2020
Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome
Edward E Neuberger, Josh J Carlson, David L Veenstra
Journal of Geriatric Oncology
|
November 27, 2022
Can we predict trial failure among older adult-specific clinical trials using trial-level factors?
Woojung Lee, Anirban Basu, Josh J Carlson, et al.
Journal of Medical Economics
|
December 12, 2012
Comparative effectiveness research in the United States: a progress report
Sean D Sullivan, Josh J Carlson, Ryan N Hansen
The Oncologist
|
October 21, 2015
Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer
Joshua A Roth, Scott D Ramsey, Josh J Carlson
Contemporary Clinical Trials
|
March 3, 2023
How does cumulative evidence from older adult-specific trials influence clinical practice? A difference-in-differences analysis in early-stage breast cancer
Woojung Lee, Anirban Basu, Josh J Carlson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2024
Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework
Boshen Jiao, Josh J Carlson, Louis P Garrison, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
April 2, 2020
Exploring Medication Adherence with P2Y<sub>12</sub> Inhibitors Using Conditional and Unconditional Quantile Regression Approaches
Kangho Suh, Anirban Basu, Josh J Carlson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2019
Defining and Managing High-Priced Cures: Healthcare Payers' Opinions
Kai Yeung, Kangho Suh, Louis P Garrison, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 17, 2015
Economic evaluation of tocilizumab monotherapy compared to adalimumab monotherapy in the treatment of severe active rheumatoid arthritis
Josh J Carlson, Sarika Ogale, Fred Dejonckheere, et al.
Journal of Medical Economics
|
February 4, 2011
Budget impact of erlotinib for maintenance therapy in advanced non-small cell lung cancer
Josh J Carlson, William B Wong, David L Veenstra, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 106) with videos related to
Sort By:
Page
of 11
Pharmacoeconomics
|
July 28, 2020
Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome
Edward E Neuberger, Josh J Carlson, David L Veenstra
Journal of Geriatric Oncology
|
November 27, 2022
Can we predict trial failure among older adult-specific clinical trials using trial-level factors?
Woojung Lee, Anirban Basu, Josh J Carlson, et al.
Journal of Medical Economics
|
December 12, 2012
Comparative effectiveness research in the United States: a progress report
Sean D Sullivan, Josh J Carlson, Ryan N Hansen
The Oncologist
|
October 21, 2015
Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer
Joshua A Roth, Scott D Ramsey, Josh J Carlson
Contemporary Clinical Trials
|
March 3, 2023
How does cumulative evidence from older adult-specific trials influence clinical practice? A difference-in-differences analysis in early-stage breast cancer
Woojung Lee, Anirban Basu, Josh J Carlson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2024
Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework
Boshen Jiao, Josh J Carlson, Louis P Garrison, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
April 2, 2020
Exploring Medication Adherence with P2Y<sub>12</sub> Inhibitors Using Conditional and Unconditional Quantile Regression Approaches
Kangho Suh, Anirban Basu, Josh J Carlson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2019
Defining and Managing High-Priced Cures: Healthcare Payers' Opinions
Kai Yeung, Kangho Suh, Louis P Garrison, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 17, 2015
Economic evaluation of tocilizumab monotherapy compared to adalimumab monotherapy in the treatment of severe active rheumatoid arthritis
Josh J Carlson, Sarika Ogale, Fred Dejonckheere, et al.
Journal of Medical Economics
|
February 4, 2011
Budget impact of erlotinib for maintenance therapy in advanced non-small cell lung cancer
Josh J Carlson, William B Wong, David L Veenstra, et al.
Page
of 11